Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2025 16:59 ET | Source: The Rosen Law Firm PA

TLX DEADLINE: ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February...
December 16, 2025 12:07 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
December 15, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
December 15, 2025 11:46 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

LOS ANGELES, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the "Company") (NASDAQ: TLX) investors of a class action on behalf of investors...
December 15, 2025 10:41 ET | Source: Schall Law

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 14, 2025 16:09 ET | Source: The Rosen Law Firm PA

TLX DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

NEW YORK, Dec. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February...
December 12, 2025 09:50 ET | Source: Schall Law

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 11, 2025 17:41 ET | Source: Bragar Eagel & Squire

TELIX CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

The lawsuit alleges Telix overstated progress on its prostate cancer candidates and supply-chain strength, making its public statements misleading.
December 11, 2025 14:00 ET | Source: The Rosen Law Firm PA

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February...
December 11, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.